15
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38612 |
Linaprazan glurate
|
Others | Others |
Linaprazan glurate 抑制外源性或内源性刺激的胃酸分泌。 Linaprazan glurate 可用于胃肠道炎症性疾病和消化性溃疡疾病的研究。 | |||
T13570 |
Benzamide Derivative 1
|
Others | Others |
Benzamide Derivative 1 苯甲酰胺衍生物,具有胃动力学活性。Benzamide Derivative 1可用于研究胃肠疾病。 | |||
T2192 |
Indazole
|
Sodium Channel | Membrane transporter/Ion channel |
Indazole 又称benzpyrazole 或isoindazone,它的衍生物表现出广泛的生物活性,吲哚唑及其衍生物可用于癌症、神经系统疾病、心血管疾病、胃肠道疾病的研究 | |||
T5051 |
Isopropamide Iodide
|
AChR | Neuroscience |
Isopropamide iodide 是长效季铵盐抗胆碱能药物。它用于研究消化性溃疡和其他胃肠道疾病,尤其是胃酸过多和运动过度。 | |||
T9842 |
5-HT2B antagonist-1
|
||
5-HT2B antagonist-1 是一种具有口服活性的5-HT2B 受体拮抗剂,IC50值为 33.4 nM。5-HT2B antagonist-1可用于以 5-HT2B 受体信号传导为特征的疾病研究,如肝细胞癌、心血管疾病或胃肠道疾病。 | |||
T67385 |
Neratinib maleate
HKI-272 maleate |
EGFR; HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Neratinib maleate (HKI-272 maleate) 是一种不可逆且具有口服活性和高选择性的 HER2 和 EGFR 抑制剂,IC50 值分别为 59 nM 和 92 nM。Neratinib maleate具有抗肿瘤活性,可用于治疗消化系统疾病、呼吸系统疾病、泌尿生殖系统疾病和皮肤和肌肉骨骼疾病,可用于研究乳腺癌和前列腺癌。 | |||
T10121 | Substance P Receptor Antagonist 1 | Others | Others |
Substance P Receptor Antagonist 1 has the potential function in gastrointestinal disorders, inflammatory diseases, respiratory, and central nervous system disorders. | |||
T39583 |
Zastaprazan
|
||
Zastaprazan, a proton pump inhibitor (WO2018008929), is utilized in the research of gastrointestinal inflammatory diseases and conditions related to gastric acid. | |||
T31396 |
Dexbrompheniramine maleate
D-Brompheniramine,Brompheniramine d-,Dexbrompheniraminum,Disophrol,Drixoral |
||
Dexbrompheniramine is an antihistamine with anticholinergic properties. It is used to treat allergic diseases such as hay fever or urticaria. It can compete with histamine for H1 receptor sites on effector cells of the gastrointestinal tract, blood vessel | |||
T69622 | Ritivixibat | ||
Ritivixibat为回肠胆汁酸转运蛋白(IBAT)抑制剂,同时也是胆汁酸调节剂,主要适用于心血管疾病、脂肪酸代谢及葡萄糖利用障碍、胃肠道和肝脏疾病的研究。 | |||
T73240 |
PDE5-IN-4
|
||
PDE5-IN-4为磷酸二酯酶5(PDE5)抑制剂,应用于急性心肌梗死及再灌注损伤、消化系统疾病、糖尿病相关损害及肝功能衰竭的研究。 | |||
T71179 |
LON63114
|
||
LON63114, also known as FFA2-Agonist-1 is a selective orthosteric agonist of human FFA2. FFA2-Agonist-1 is potentially useful in the treatment of gastrointestinal disorders and inflammatory bowel diseases. LON63114 was reported in WO2011076732. This product has no formal name at the moment. For the convenience of communication, a temporal code name was therefore proposed according to MedKoo Chemical Nomenclature (see web page: https://www.medkoo.com/page/naming). | |||
T72812 |
(R)-Tegoprazan
|
||
(R)-Tegoprazan (example 3) 是一种苯并咪唑衍生物,是一种有效的胃H+/K+-ATP 酶抑制剂,对犬肾 Na+/K+-ATPase 的IC50为 98 nM。(R)-Tegoprazan 具有胃肠道疾病研究的潜力。 | |||
T4633 |
Asimadoline
EMD-61753,阿西马朵林 |
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
Asimadoline (EMD-61753) 是一种 κ-阿片(κ-opioid)受体激动剂,对豚鼠和人重组 κ-opioid 的IC50值分别为 5.6 和 1.2 nM。它可改善糖尿病大鼠的异常性疼痛,具有外周抗炎作用,并有用于肠易激综合征的研究潜力。 | |||
T63809 |
Ansornitinib
|
||
Ansornitinib 是口服具有活力的双激酶抑制剂,能够抑制血小板衍生生长因子受体 (PDGFR) 和血管内皮生长因子受体 (VEGFR2)。Ansornitinib 是一种抗纤维化剂,能够用于研究肺部,肝脏,肾脏以及胃肠等纤维化疾病。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0700 |
Ursodeoxycholic acid
熊去氧胆酸,UDCA,Ursodiol |
Potassium Channel; Endogenous Metabolite | Membrane transporter/Ion channel; Metabolism |
Ursodeoxycholic acid (UDCA)是一种有效的肝脏特异性脂肪酸转运蛋白 5 (FATP5) 抑制剂,通过 FATP5 依赖性方式抑制原代肝细胞摄取长链脂肪酸。Ursodeoxycholic acid 能够抑制胆固醇的吸收,用于溶解胆结石,并具有研究与肥胖相关的脂肪肝疾病的潜力。 | |||
T29078 |
Ursodeoxycholic acid sodium
UDCA Na,UDCA sodium,Sodium Ursodeoxycholate,熊去氧胆酸钠盐,Ursodiol sodium,Ursodeoxycholic Acid (sodium salt),Ursodeoxycholate sodium |
FXR; Endogenous Metabolite; GPCR19 | GPCR/G Protein; Metabolism |
Ursodeoxycholic acid sodium (Sodium Ursodeoxycholate) 是一种天然存在的次级胆汁酸,具有抗炎和细胞保护活性。Ursodeoxycholic acid sodium 作为信号分子,通过与胆汁酸激活受体相互作用发挥其作用,包括 G 蛋白偶联胆汁酸受体 5 (TGR5) 和法尼醇 X 受体 (FXR)。 | |||
T38108 |
Fulvic Acid
|
Antioxidant; PDE | Metabolism; oxidation-reduction |
Fulvic Acid 是一种来自土壤、沉积物或水生环境中微生物产生的腐殖质的天然产物,是一种首次青霉菌中分离出的酚酸和真菌代谢产物。Fulvic Acid 抑制淀粉样蛋白b (17-42) (AB17-42)二聚化,破坏预先形成的AB17-42三聚体,并结合到磷酸二酯酶5A (PDE5A)的催化位点,可以调节机体免疫系统,影响细胞的氧化状态,改善胃肠功能。Fulvic Acid 可作为氧化剂或还原剂, 具有研究糖尿病等慢性炎症性疾病的潜力。 | |||
TN1834 |
Kobusin
去甲槟郎碱,自旋七叶素 |
Others; NOS; NF-κB | Immunology/Inflammation; NF-κB; Others |
Kobusin, a Calmodulin inhibitor, shows mild antiplasmodial,anti-inflammatory, and cytotoxic activities; it may be beneficial for the treatment of neuro-inflammatory diseases through the inhibition of iNOS expression and peroxynitrite scavenging potential. Kobusin can mildly reduce gastrointestinal motility in mice, it activates CFTR and CaCCgie chloride channel activities in mouse colonic epithelia and shows inhibitory effects toward ANO1/CaCC-mediated short-circuit currents in ANO1/CaCC-express... |